Lemaitre Vascular (LMAT) Misses Q3 EPS by 4c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $87.92 +9.08%
Financial Fact:
Total operating expenses: 11.68M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Total operating expenses: 11.68M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q3 EPS of $0.65, $0.04 worse than the analyst estimate of $0.69. Revenue for the quarter came in at $68 million versus the consensus estimate of $67.74 million.
GUIDANCE:
Lemaitre Vascular sees Q4 2026 revenue of $69.9-71.9 million, versus the consensus of $72.24 million.
Lemaitre Vascular sees FY2026 revenue of $274.8-276.8 million, versus the consensus of $276.5 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- BillionToOne, Inc. (BLLN) Tops Q3 EPS by 23c; Offers Guidance
- Enact Holdings (ACT) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
